ClinicalCodes.org
An online clinical codes repository to improve validity and reproducibility of medical database research
Research article:
Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework
Reference:
Doran, Tim; Kontopantelis, Evangelos; Valderas, Jose M; Campbell, Stephen; Roland, Martin; Salisbury, Chris; Reeves, David(2011) Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework. British Medical Journal, doi: 10.1136/bmj.d3590
- Link to fulltext article
- Abstract
- Objective: To investigate whether the incentive scheme for UK general practitioners led them to neglect activities not included in the scheme. Design: Longitudinal analysis of achievement rates for 42 activities (23 included in incentive scheme, 19 not included) selected from 428 identified indicators of quality of care. Setting: 148 general practices in England (653 500 patients). Main outcome measures: Achievement rates projected from trends in the pre-incentive period (2000-1 to 2002-3) and actual rates in the first three years of the scheme (2004-5 to 2006-7). Results: Achievement rates improved for most indicators in the pre-incentive period. There were significant increases in the rate of improvement in the first year of the incentive scheme (2004-5) for 22 of the 23 incentivised indicators. Achievement for these indicators reached a plateau after 2004-5, but quality of care in 2006-7 remained higher than that predicted by pre-incentive trends for 14 incentivised indicators. There was no overall effect on the rate of improvement for non-incentivised indicators in the first year of the scheme, but by 2006-7 achievement rates were significantly below those predicted by pre-incentive trends. Conclusions: There were substantial improvements in quality for all indicators between 2001 and 2007. Improvements associated with financial incentives seem to have been achieved at the expense of small detrimental effects on aspects of care that were not incentivised.
- Author for correspondence
- Tim Doran
- Email for correspondence
- tim.doran@york.ac.uk
Code list: SMI drugs
23 codes in list
| Code | Coding system | Description | Entity type | List name | BNF_header | BNF_code | drug_substance_name |
|---|---|---|---|---|---|---|---|
| 00141001 | GPRD_product_code | CAMCOLIT 250 tabs | drug | SMI drugs | NA | 4020300 | NA |
| 00534001 | GPRD_product_code | LISKONUM tabs 450mg | drug | SMI drugs | NA | 4020300 | NA |
| 00782001 | GPRD_product_code | PRIADEL tabs 200mg | drug | SMI drugs | NA | 4020300 | NA |
| 00782002 | GPRD_product_code | PRIADEL tabs 400mg | drug | SMI drugs | NA | 4020300 | NA |
| 01185001 | GPRD_product_code | CAMCOLIT 400 tabs | drug | SMI drugs | NA | 4020300 | NA |
| 02020009 | GPRD_product_code | LITHIUM CARBONATE mr tab 400mg [APS] | drug | SMI drugs | NA | 4020300 | NA |
| 02283001 | GPRD_product_code | LITHIUM CITRATE oral liq 1.018g/5ml | drug | SMI drugs | NA | 4020300 | NA |
| 02294001 | GPRD_product_code | LI-LIQUID soln 509mg/5ml | drug | SMI drugs | NA | 4020300 | NA |
| 02294002 | GPRD_product_code | LI-LIQUID soln 1.018g/5ml | drug | SMI drugs | NA | 4020300 | NA |
| 02325007 | GPRD_product_code | LITHIUM 250 MG CAP | drug | SMI drugs | NA | 0 | NA |
| 02465001 | GPRD_product_code | LITAREX CR tablets 564mg | drug | SMI drugs | NA | 4020300 | NA |
| 03134007 | GPRD_product_code | LITHIUM 10.8 MMOLS/5MLS LIQ | drug | SMI drugs | NA | 0 | NA |
| 03995001 | GPRD_product_code | LITHIUM CARBONATE mr tab 200mg | drug | SMI drugs | NA | 4020300 | NA |
| 03995002 | GPRD_product_code | LITHIUM CARBONATE tabs 250mg | drug | SMI drugs | NA | 4020300 | NA |
| 03995003 | GPRD_product_code | LITHIUM CARBONATE mr tab 300mg | drug | SMI drugs | NA | 4020300 | NA |
| 03996001 | GPRD_product_code | LITHIUM CARBONATE mr tab 400mg | drug | SMI drugs | NA | 4020300 | NA |
| 03997001 | GPRD_product_code | LITHIUM CARBONATE mr tab 450mg | drug | SMI drugs | NA | 4020300 | NA |
| 03998001 | GPRD_product_code | PHASAL tabs 300mg | drug | SMI drugs | NA | 4020300 | NA |
| 03999001 | GPRD_product_code | LITHIUM CITRATE mr tab 564mg | drug | SMI drugs | NA | 4020300 | NA |
| 03999002 | GPRD_product_code | LITHIUM CITRATE sf liq 520mg/5ml | drug | SMI drugs | NA | 4020300 | NA |
| 03999003 | GPRD_product_code | LITHIUM CITRATE oral liq 509mg/5ml | drug | SMI drugs | NA | 4020300 | NA |
| 06587001 | GPRD_product_code | PRIADEL liq 520mg/5ml | drug | SMI drugs | NA | 4020300 | NA |
| 07457001 | GPRD_product_code | LITHONATE sr tab 400mg | drug | SMI drugs | NA | 4020300 | NA |
Please log in to leave a comment.
Code list links:
ClinicalCodes is a project at the University of Manchester Institute of Population Health
The ClinicalCodes project is funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)